- 24/7 Wall St.•5 hours ago
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
- Investor's Business Daily•21 hours ago
Amgen will likely beat Eli Lilly, Alder and Teva to market with an antibody-blocking migraine med.
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||80.43 x 300|
|Ask||80.44 x 700|
|Day's Range||80.03 - 80.65|
|52wk Range||67.88 - 88.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.61|
|Avg Vol (3m)||3,444,567|
|Dividend & Yield||2.04 (2.53%)|